Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
Cheng Zhang, Mengnan Shi, Woonghee Kim, et al.
EBioMedicine (2022) Vol. 83, pp. 104214-104214
Open Access | Times Cited: 23

Showing 23 citing articles:

Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation
Han Jin, Cheng Zhang, Martin Zwahlen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Genome-scale models in human metabologenomics
Adil Mardinoğlu, Bernhard Ø. Palsson
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 10
Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
Abdulahad Bayraktar, Xiangyu Li, Woonghee Kim, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
SAH is a major metabolic sensor mediating worsening metabolic crosstalk in metabolic syndrome
Ramón Cueto, Wen Shen, Lu Liu, et al.
Redox Biology (2024) Vol. 73, pp. 103139-103139
Open Access | Times Cited: 5
Integration of transcriptomics, metabolomics, and lipidomics reveals the mechanisms of doxorubicin-induced inflammatory responses and myocardial dysfunction in mice
Xin Tan, Rongyi Zhang, Meide Lan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114733-114733
Open Access | Times Cited: 12
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Occam Kelly Graves, Woonghee Kim, Mehmet Özcan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114486-114486
Open Access | Times Cited: 11
Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
Woonghee Kim, Mengzhen Li, Han Jin, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107727-107727
Open Access | Times Cited: 11
Novel drug targets and molecular mechanisms for sarcopenia based on systems biology
Atakan Burak Ceyhan, Mehmet Özcan, Woonghee Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116920-116920
Open Access | Times Cited: 4
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue
Alvile Kasarinaite, Maria Jiménez Ramos, Mariana Beltran-Sierra, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Drug Repurposing for Non-Alcoholic Fatty Liver Disease by Analyzing Networks Among Drugs, Diseases, and Genes
Md. Altaf-Ul-Amin, Ahmad Kamal Nasution, Rumman Mahfujul Islam, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 255-255
Open Access
Targeting PKLR in liver diseases
Meng Yuan, Mengnan Shi, Hong Yang, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
J. Y. Liu, Dongmei Wang, Ziyan Xie, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1199-1199
Open Access | Times Cited: 8
Cav3.2 deletion attenuates nonalcoholic fatty liver disease in mice
Xue Li, Chengyun Hu, Shanshan Luo, et al.
Gene (2024) Vol. 929, pp. 148812-148812
Open Access | Times Cited: 2
Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
Xinmeng Liao, Mehmet Özcan, Mengnan Shi, et al.
Bioinformatics (2023) Vol. 39, Iss. 11
Open Access | Times Cited: 4
Synthesis, spectroscopic characterization, DFT and molecular docking of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) naphthalene-1-sulfonamide derivatives
Sajda Ashraf, Shazia Iqbal, Jihad Sebhaoui, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138470-138470
Closed Access | Times Cited: 1
Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
Shazia Iqbal, Jihad Sebhaoui, Sajda Ashraf, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107425-107425
Closed Access | Times Cited: 1
Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins
Shazia Iqbal, Md. Zahidul Islam, Sajda Ashraf, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7986-7986
Open Access | Times Cited: 1
Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach
Ali Kaynar, Mehmet Özcan, Xiangyu Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7868-7868
Open Access | Times Cited: 1
Synthesis of novel tetrahydrobenzo[b]thiophene-3-carbonitrile (THBTC)-based heterocycles: Structural insights, reactivity profiles, and in-silico bioactivity studies
Jihad Sebhaoui, Sajda Ashraf, Shazia Iqbal, et al.
Journal of Molecular Structure (2024), pp. 141110-141110
Closed Access | Times Cited: 1
Development and in Vitro−in Vivo Correlation Evaluation of IMM-H014 Extended–Release Tablets for the Treatment of Fatty Liver Disease
Chi Zhang, Huihui Shao, Zunsheng Han, et al.
(2023)
Open Access | Times Cited: 3
The Regulative Effect and Mechanism in a MetS Mice Model of Functional Components in Freeze‐Dried Powder from Phyllanthus emblica L. Fruit
Y Wei, Yongping Huang, Yisheng Huang, et al.
Journal of Food Biochemistry (2024) Vol. 2024, Iss. 1
Open Access
Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease
Chi Zhang, Huihui Shao, Zunsheng Han, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12328-12328
Open Access | Times Cited: 1
WITHDRAWN: SAH is a major metabolic sensor mediating worsening metabolic crosstalk in metabolic syndrome
Ramón Cueto, Wen Shen, Lu Liu, et al.
Redox Biology (2024), pp. 103113-103113
Open Access
Page 1

Scroll to top